A bullet against gallbladder cancer

    loading  Checking for direct PDF access through Ovid

Abstract

ERBB2/3 mutations in gallbladder cancer are associated with immunosuppression and aggressive tumor development and can be targeted by ERBB2/3 inhibitors.

Related Topics

    loading  Loading Related Articles